Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemiaDiabetologia, 2020-10, Vol.63 (10), p.2007-2021 [Peer Reviewed Journal]This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-020-05245-x ;PMID: 32894311Full text available |
|
2 |
Material Type: Article
|
Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitusNature reviews. Endocrinology, 2020-10, Vol.16 (10), p.556-577 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5029 ;ISSN: 1759-5037 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-020-0392-2 ;PMID: 32855502Full text available |
|
3 |
Material Type: Article
|
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular diseaseDiabetes & metabolism, 2018-12, Vol.44 (6), p.457-464 [Peer Reviewed Journal]2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.09.005 ;PMID: 30266577Full text available |
|
4 |
Material Type: Article
|
Metformin and COVID-19: From cellular mechanisms to reduced mortalityDiabetes & metabolism, 2020-11, Vol.46 (6), p.423-426 [Peer Reviewed Journal]2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.07.006 ;PMID: 32750451Full text available |
|
5 |
Material Type: Article
|
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 DiabetesThe New England journal of medicine, 2011-03, Vol.364 (10), p.907-917 [Peer Reviewed Journal]Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1007994 ;PMID: 21388309 ;CODEN: NEJMAGFull text available |
|
6 |
Material Type: Article
|
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetesDiabetes & metabolism, 2019-04, Vol.45 (2), p.110-121 [Peer Reviewed Journal]2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.10.003 ;PMID: 30477733Full text available |
|
7 |
Material Type: Article
|
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonistsDiabetes & metabolism, 2022-11, Vol.48 (6), p.101390-101390, Article 101390 [Peer Reviewed Journal]2022 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101390 ;PMID: 36170946Full text available |
|
8 |
Material Type: Article
|
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studiesDiabetes & metabolism, 2021-11, Vol.47 (6), p.101220-101220, Article 101220 [Peer Reviewed Journal]2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.101220 ;PMID: 33359486Full text available |
|
9 |
Material Type: Article
|
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsDiabetes & metabolism, 2020-06, Vol.46 (3), p.186-196 [Peer Reviewed Journal]2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.01.002 ;PMID: 32007623Full text available |
|
10 |
Material Type: Article
|
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?Diabetologia, 2019-07, Vol.62 (7), p.1113-1122 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Diabetologia is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-019-4889-y ;PMID: 31089754Full text available |
|
11 |
Material Type: Article
|
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter]Diabetologia, 2021-10, Vol.64 (10), p.2345-2347 [Peer Reviewed Journal]This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-021-05511-6 ;PMID: 34324020Full text available |
|
12 |
Material Type: Article
|
Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockersDiabetes & metabolism, 2022-03, Vol.48 (2), p.101315-101315, Article 101315 [Peer Reviewed Journal]2021 Elsevier Masson SAS ;Copyright © 2021 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2021.101315 ;PMID: 34910981Full text available |
|
13 |
Material Type: Article
|
Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitroDiabetologia, 2020-11, Vol.63 (11), p.2385-2395 [Peer Reviewed Journal]This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020 ;This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-020-05232-2 ;PMID: 32728889Full text available |
|
14 |
Material Type: Article
|
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in AcromegalyThe journal of clinical endocrinology and metabolism, 2020-09, Vol.105 (9), p.2964-2974 [Peer Reviewed Journal]Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;Copyright © Oxford University Press 2015 ;Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2020 Oxford University Press ;Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;ISSN: 1945-7197 ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa387 ;PMID: 32589751Full text available |
|
15 |
Material Type: Article
|
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical interventionDiabetologia, 2024-02, Vol.67 (2), p.333-345 [Peer Reviewed Journal]The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06032-0Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese ratsPloS one, 2011-09, Vol.6 (9), p.e25565 [Peer Reviewed Journal]COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Deblon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Deblon et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0025565 ;PMID: 21980491Full text available |
|
17 |
Material Type: Article
|
Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male MiceEndocrinology (Philadelphia), 2023-03, Vol.164 (5), p.1 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2023 Oxford University Press ;The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 1945-7170 ;ISSN: 0013-7227 ;EISSN: 1945-7170 ;DOI: 10.1210/endocr/bqad055 ;PMID: 36964914Full text available |
|
18 |
Material Type: Article
|
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitorsDiabetes & metabolism, 2022-11, Vol.48 (6), p.101405, Article 101405 [Peer Reviewed Journal]2022 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101405 ;PMID: 36334794Full text available |
|
19 |
Material Type: Article
|
Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunctionAmerican journal of physiology: endocrinology and metabolism, 2022-03, Vol.322 (3), p.E307-E318 [Peer Reviewed Journal]Copyright American Physiological Society Mar 2022 ;Published by the American Physiological Society. ;ISSN: 0193-1849 ;ISSN: 1522-1555 ;EISSN: 1522-1555 ;DOI: 10.1152/ajpendo.00234.2021 ;PMID: 35128957Full text available |
|
20 |
Material Type: Article
|
GLP-1 receptor agonists and heart failure in diabetesDiabetes & metabolism, 2017-04, Vol.43, p.2S13-2S19 [Peer Reviewed Journal]Elsevier Masson SAS ;2017 Elsevier Masson SAS ;2017 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/S1262-3636(17)30068-X ;PMID: 28431666Full text available |